A peripheral blood biomarker estimates probability of survival: The neutrophil-lymphocyte ratio in noncancer patients Journal Article


Authors: Davis, J. L.; Moutinho, V. Jr; Panageas, K. S.; Coit, D. G.
Article Title: A peripheral blood biomarker estimates probability of survival: The neutrophil-lymphocyte ratio in noncancer patients
Abstract: Aim: Inflammatory biomarkers are associated with aging and disease-specific outcomes. We propose neutrophil-lymphocyte ratio (NLR) informs survival in a noncancer-bearing population. Patients & methods: Retrospective cohort study of patients with a noncancer diagnosis. Calculation of NLR, ascertainment of age, gender, race, cardiovascular disease and diabetes status, and association with survival was determined. Results: Elevated NLR was associated with worse overall survival, independent of age, gender and comorbid status. Overall survival was significantly worse for patients with high versus low NLR. Conclusion: Elevated NLR is associated with worse overall survival in noncancer patients. It remains unclear whether NLR reflects an acute inflammatory state, depressed host immune competence or both. NLR may simply be another predictor of survival, or potentially a modifiable risk factor. © 2016 Future Medicine Ltd.
Keywords: inflammation; biomarker; outcomes; neutrophil-lymphocyte ratio; noncancer
Journal Title: Biomarkers in Medicine
Volume: 10
Issue: 9
ISSN: 1752-0363
Publisher: Future Medicine  
Date Published: 2016-09-01
Start Page: 953
End Page: 957
Language: English
DOI: 10.2217/bmm-2016-0103
PROVIDER: scopus
PUBMED: 27537355
PMCID: PMC5493963
DOI/URL:
Notes: Article -- Export Date: 3 October 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics